The inhibition of AKT by shikonin activated the forkhead box (FOX)O3a/early growth response protein (EGR)1 signaling cascade and enhanced the expression of the target gene Bim, leading to apoptosis in lung cancer cells (Jeung et al., 2016). The gene discussed is BCL2L11; the disease is lung carcinoma.